These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 27815512)

  • 1. Schizophrenia: Impact of psychopathology, faith healers and psycho-education on adherence to medications.
    Abdel Aziz K; Elamin MH; El-Saadouni NM; El-Gabry DA; Barakat M; Alhayyas F; Moselhy HF
    Int J Soc Psychiatry; 2016 Dec; 62(8):719-725. PubMed ID: 27815512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reasons associated with treatment non-adherence in schizophrenia in a Pakistan cohort.
    Ahmad I; Khalily MT; Hallahan B
    Asian J Psychiatr; 2017 Dec; 30():39-43. PubMed ID: 28738259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving treatment adherence in patients with schizophrenia.
    Kane JM
    J Clin Psychiatry; 2011 Sep; 72(9):e28. PubMed ID: 21951990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment adherence and insight in schizophrenia.
    Bitter I; Fehér L; Tényi T; Czobor P
    Psychiatr Hung; 2015; 30(1):18-26. PubMed ID: 25867885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insight and medication adherence in schizophrenia: An analysis of the CATIE trial.
    Kim J; Ozzoude M; Nakajima S; Shah P; Caravaggio F; Iwata Y; De Luca V; Graff-Guerrero A; Gerretsen P
    Neuropharmacology; 2020 May; 168():107634. PubMed ID: 31077729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adherence to antipsychotics and cardiometabolic medication: association with health care utilization and costs.
    Hansen RA; Maciejewski M; Yu-Isenberg K; Farley JF
    Psychiatr Serv; 2012 Sep; 63(9):920-8. PubMed ID: 22706887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pilot study of barriers to medication adherence in schizophrenia.
    Hudson TJ; Owen RR; Thrush CR; Han X; Pyne JM; Thapa P; Sullivan G
    J Clin Psychiatry; 2004 Feb; 65(2):211-6. PubMed ID: 15003075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Drug compliance and health locus of control in schizophrenia].
    Combes C; Feral F
    Encephale; 2011 May; 37 Suppl 1():S11-8. PubMed ID: 21600328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adherence to antipsychotic drug treatment in early-episode schizophrenia: a six-month naturalistic follow-up study.
    Baloush-Kleinman V; Levine SZ; Roe D; Shnitt D; Weizman A; Poyurovsky M
    Schizophr Res; 2011 Aug; 130(1-3):176-81. PubMed ID: 21636254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature.
    Lacro JP; Dunn LB; Dolder CR; Leckband SG; Jeste DV
    J Clin Psychiatry; 2002 Oct; 63(10):892-909. PubMed ID: 12416599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How do socio-demographic and clinical factors interact with adherence attitude profiles in schizophrenia? A cluster-analytical approach.
    Beck EM; Cavelti M; Wirtz M; Kossowsky J; Vauth R
    Psychiatry Res; 2011 May; 187(1-2):55-61. PubMed ID: 21074860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substance abuse and the management of medication nonadherence in schizophrenia.
    Wilk J; Marcus SC; West J; Countis L; Hall R; Regier DA; Olfson M
    J Nerv Ment Dis; 2006 Jun; 194(6):454-7. PubMed ID: 16772865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of early nonadherence to oral antipsychotics on clinical and economic outcomes among patients with schizophrenia.
    Offord S; Lin J; Mirski D; Wong B
    Adv Ther; 2013 Mar; 30(3):286-97. PubMed ID: 23483449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medication Adherence Decisions in Patients With Schizophrenia.
    Kikkert MJ; Dekker J
    Prim Care Companion CNS Disord; 2017 Dec; 19(6):. PubMed ID: 29216418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attitudes toward antipsychotic medications as a useful feature in exploring medication non-adherence in schizophrenia.
    Samalin L; de Chazeron I; Blanc O; Brunel L; Fond G; Llorca PM
    Schizophr Res; 2016 Dec; 178(1-3):1-5. PubMed ID: 27637362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of patient and clinician perspectives in the assessment of antipsychotic medication adherence.
    Barbui C; Kikkert M; Mazzi MA; Becker T; Bindman J; Schene A; Nosè M; Helm H; Thornicroft G; Tansella M
    Psychopathology; 2009; 42(5):311-7. PubMed ID: 19672133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors associated with adherence to treatment with olanzapine and other atypical antipsychotic medications in patients with schizophrenia.
    Liu-Seifert H; Osuntokun OO; Feldman PD
    Compr Psychiatry; 2012 Jan; 53(1):107-15. PubMed ID: 21310400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective memory predicts medication management ability and correlates with non-adherence to medications in individuals with clinically stable schizophrenia.
    Lam JW; Lui SS; Wang Y; Chan RC; Cheung EF
    Schizophr Res; 2013 Jul; 147(2-3):293-300. PubMed ID: 23631929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors associated with antipsychotic medication adherence in community-based patients with schizophrenia in Hong Kong: a cross sectional study.
    Bressington D; Mui J; Gray R
    Int J Ment Health Nurs; 2013 Feb; 22(1):35-46. PubMed ID: 22738372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug attitude and other predictors of medication adherence in schizophrenia: 12 months of electronic monitoring (MEMS(®)) in the Swedish COAST-study.
    Brain C; Allerby K; Sameby B; Quinlan P; Joas E; Karilampi U; Lindström E; Eberhard J; Burns T; Waern M
    Eur Neuropsychopharmacol; 2013 Dec; 23(12):1754-62. PubMed ID: 24091164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.